此页面是自动翻译的,不保证翻译的准确性。请参阅 英文版 对于源文本。

Early- Warning and Precision-Intervention Technologies for Decline in Intrinsic Capacity

Development and Application of Early- Warning and Precision-Intervention Technologies for Decline in Intrinsic Capacity Among Older Adults

This clinical study aims to develop and apply early-warning and precision-intervention technologies for older adults with declining intrinsic capacity. It intends to identify key digital biomarkers, build dynamic prediction models, and verify the effectiveness of a human-computer interactive adaptive closed-loop intervention system, so as to shift geriatric health management from reactive medical care to proactive health management. The main questions it aims to answer are:

Can multi-modal digital data enable early warning of intrinsic capacity decline among community-dwelling older adults?

Does the AI-driven personalized stepped intervention reduce the incidence of intrinsic capacity decline and adverse health events in older adults?Researchers will compare an integrated whole-course intrinsic-capacity management platform intervention versus routine community-based geriatric health services through a cluster-randomized controlled trial.Participants will:

Complete baseline multi-modal assessments including standard scales and wearable-device-based physiological monitoring Receive follow-up assessments every 3-6 months for 12-24 months in the cohort phase Be assigned to either the intervention group or the control group for a 6-month intervention period Undergo multi-dimensional evaluations at baseline, month 3, month 6 and month 12 Comply with health-management requirements or routine community health services according to group assignment

研究概览

研究类型

介入性

注册 (估计的)

500

阶段

  • 不适用

联系人和位置

本节提供了进行研究的人员的详细联系信息,以及有关进行该研究的地点的信息。

学习联系方式

参与标准

研究人员寻找符合特定描述的人,称为资格标准。这些标准的一些例子是一个人的一般健康状况或先前的治疗。

资格标准

适合学习的年龄

18年 至 100年 (成人、年长者)

接受健康志愿者

是的

有资格学习的性别

全部

描述

Inclusion Criteria:

  • Aged 60 years or older
  • Residing stably in the affiliated community for at least 6 months
  • Conscious and able to cooperate with assessments and device operation (individuals at risk of mild cognitive impairment may participate with assistance)
  • Voluntary participation with written informed consent signed

Exclusion Criteria:

  • Severe cognitive impairment or acute phase of psychiatric illness, unable to cooperate with assessment or intervention
  • Severe heart, lung, liver, or kidney failure, or terminal stage of malignant tumor
  • Skin damage, infection, or other conditions affecting wearing of wearable devices
  • Judged by the investigator to be unsuitable for participation in the study

学习计划

本节提供研究计划的详细信息,包括研究的设计方式和研究的衡量标准。

研究是如何设计的?

设计细节

  • 主要用途:预防
  • 分配:随机化
  • 介入模型:并行分配
  • 屏蔽:单身的

武器和干预

参与者组/臂
干预/治疗
实验性的:Intervention

Participants receive the Intrinsic Capacity (IC) whole-course management platform intervention for 6 months, with follow-up to 12 months. The intervention includes: (1) an LLM-driven multi-agent AI health coach (knowledge-delivery, empathetic communication, and quality supervision agents); (2) continuous wearable device monitoring (blood pressure, heart rate, activity pattern, sleep architecture, skin temperature, dual-task gait); and (3) risk-stratified, individualized stepped prescriptions covering five domains: nutrition, exercise, cognition, psychological health, and sensory function. The platform collects adherence data in real time and dynamically adjusts the intervention plan (Just-In-Time Adaptive Intervention, JITAI).

A multi-agent, LLM-driven AI health coach system (knowledge-delivery, empathetic communication, and quality supervision agents) combined with a Just-In-Time Adaptive Intervention (JITAI) decision engine, delivering risk-stratified, individualized stepped interventions across five domains: nutrition, exercise, cognition, psychological health, and sensory function. Delivered for 6 months via the IC whole-course management platform.

Wearable devices continuously monitor dynamic blood pressure, heart rate, activity patterns, sleep architecture, skin temperature, and dual-task gait. Device data are uploaded in real time to the platform and used to trigger adaptive, individualized intervention recommendations.

无干预:Control

Participants receive routine community health management services for older adults as usually provided by the community health service center, including regular physical examination and standard health education. Intervention duration is 6 months, with follow-up to 12 months.

研究衡量的是什么?

主要结果指标

结果测量
措施说明
大体时间
Incidence of Intrinsic Capacity Decline
大体时间:From baseline to 12 months

The proportion of participants who experience a clinically significant decline in at least one of the five WHO intrinsic capacity domains during follow-up. Each domain is assessed at baseline and at 3, 6, and 12 months using a single prespecified instrument: cognition (MoCA), locomotion (SPPB), psychological status (GDS-15), vitality (MNA-SF), and sensory function (vision and hearing tests). Each instrument is converted against a prespecified threshold into a binary decline judgement (yes/no). These five binary judgements are aggregated into one composite endpoint: a participant is counted as having an event if decline is present in any domain. Only one value is reported, the percentage of participants meeting this composite definition at 12 months, expressed as a percentage of participants.

From baseline to 12 months
Incidence of Adverse Health Events
大体时间:From baseline to 12 months

The proportion of participants experiencing at least one event of a composite of adverse health events (falls, emergency department visits, hospitalizations, or death) during follow-up. Each event type is recorded as a binary occurrence and verified against medical records at the 3-, 6-, and 12-month assessments. The four event types are aggregated into a single composite binary endpoint: each participant is counted once if any component event occurs. Only one value is reported, the percentage of participants with at least one component event at 12 months, expressed as a percentage of participants.

From baseline to 12 months

次要结果测量

结果测量
措施说明
大体时间
Change in Cognitive Function (MoCA Score)
大体时间:Baseline to 12 months

Change from baseline in the Montreal Cognitive Assessment (MoCA) score at 3, 6, and 12 months. Reported as change in MoCA score points; only one value is reported.

Baseline to 12 months
Change in Locomotion (SPPB Score)
大体时间:Baseline to 12 months

Change from baseline in the Short Physical Performance Battery (SPPB) score at 3, 6, and 12 months. Reported as change in SPPB score points; only one value is reported.

Baseline to 12 months
Change in Psychological Status (GDS-15 Score)
大体时间:Baseline to 12 months

Change from baseline in the 15-item Geriatric Depression Scale (GDS-15) score at 3, 6, and 12 months. Reported as change in GDS-15 score points; only one value is reported.

Baseline to 12 months
Change in Vitality / Nutritional Status (MNA-SF Score)
大体时间:Baseline to 12 months

Change from baseline in the Mini Nutritional Assessment Short-Form (MNA-SF) score at 3, 6, and 12 months. Reported as change in MNA-SF score points; only one value is reported.

Baseline to 12 months
Change in Sensory Function Score
大体时间:Baseline to 12 months

Vision and hearing test results are converted according to a prespecified grading rule into a single sensory domain score ranging from 0 to 100. Change from baseline in this sensory domain score is assessed at 3, 6, and 12 months. Reported as change in score points; only one value is reported.

Baseline to 12 months
Change in Intrinsic Capacity Digital Index
大体时间:Baseline to 12 months

Change from baseline in the composite Intrinsic Capacity Digital Index (0-10), derived by aggregating multimodal wearable and assessment data at 3, 6, and 12 months. Reported as change in index score points; only one value is reported.

Baseline to 12 months

合作者和调查者

在这里您可以找到参与这项研究的人员和组织。

研究记录日期

这些日期跟踪向 ClinicalTrials.gov 提交研究记录和摘要结果的进度。研究记录和报告的结果由国家医学图书馆 (NLM) 审查,以确保它们在发布到公共网站之前符合特定的质量控制标准。

研究主要日期

学习开始 (估计的)

2026年12月31日

初级完成 (估计的)

2028年8月31日

研究完成 (估计的)

2028年12月31日

研究注册日期

首次提交

2026年11月2日

首先提交符合 QC 标准的

2026年11月9日

首次发布 (实际的)

2026年11月16日

研究记录更新

最后更新发布 (实际的)

2026年11月16日

上次提交的符合 QC 标准的更新

2026年11月9日

最后验证

2026年11月1日

更多信息

与本研究相关的术语

其他研究编号

  • KY-2026-0221
  • No.2026C02A1144 (其他标识符:Key R&D Program of Zhejiang)

计划个人参与者数据 (IPD)

计划共享个人参与者数据 (IPD)?

不

药物和器械信息、研究文件

研究美国 FDA 监管的药品

不

研究美国 FDA 监管的设备产品

不

此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.

订阅